MGO, NaB and AI-1 were purchased from Sigma-Aldrich; Merck KGaA. N-acetyl-cysteine (NAC), Colivelin, cct020312 and ruxolitinib were purchased from MedChemExpress. KN-93 was purchased from Selleck Chemicals. DCFDA was purchased from Abcam. Referring to previous studies (21 (link)–27 (link)), the concentrations of these agents used in the present study were chosen.